Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Better care can begin with bleeding assessment tools and a doctor who understands how bleeding disorders impact women’s healt…
CSL joins with the global bleeding disorders community – including women and girls – to support empowerment and access to tre…
The JNC, celebrating its 22nd year, hosts children and teens in the bleeding disorders community for a weekend full of sports…
Obstetrician-gynecologists can improve women’s health by screening for bleeding disorders like von Willebrand Disease, which …
The Chicago-area event begins April 28 and offers hematology fellows a chance to connect and learn about benign hematology.
Study examines the effect on quality of life for parents of children who have the rare bleeding disorder.
The National Hemophilia Foundation changed its name and officially broadened its mission to include all bleeding disorders. G…
In healthy coagulation, the essential process stops the body from bleeding. It’s a finely tuned cascade that relies on severa…
CSL Behring, which makes medicines for rare bleeding disorders, recently hosted hematology/oncology fellows at an in-person l…
A new study looked at the worldwide prevalence of VWD, a bleeding disorder. It found reported cases were much higher in wealt…
Joint problems may be a variable affecting emotional health and quality of life, new study suggests.
CSL Plasma’s Exie Mayes manages a CSL Plasma Center in Delaware. Her 7-year-old daughter Eden relies on a plasma-based medici…
Americas
Asia Pacific
Middle East
Europe
